Tuesday - November 3, 2026
Mayo Clinic study explores cerebrospinal fluid DNA testing when brain tumor diagnosis is uncertain
October 26, 2026
ROCHESTER, Minnesota, Oct. 26 [Category: BizHospital] -- The Mayo Clinic issued the following news release:

* * *

Mayo Clinic study explores cerebrospinal fluid DNA testing when brain tumor diagnosis is uncertain

*

ROCHESTER, Minn., and PHOENIX -- A Mayo Clinic study published in the Journal of Neuro-Oncology suggests that analyzing DNA in cerebrospinal fluid could provide another source of information when MRI cannot provide a clear brain tumo . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products